Getting under your skin: Sorrento leveraging novel drug delivery platform to treat melanoma in tie-up with Mayo Clinic

Sorrento Technologies, a biotech firm developing novel treatments for COVID-19 and aggressive cancers such as melanoma, has received FDA clearance to start a research collaboration together with Mayo Clinic.